3 — 9 (47) 2022 — Khushvaktova M.F., Achilova D.N., ANALYSIS OF THE CAUSES OF TOXIC EPIDERMAL NECROLYSIS IN CHILDREN

ANALYSIS OF THE CAUSES OF TOXIC EPIDERMAL NECROLYSIS IN CHILDREN

Khushvaktova M.F.,

Achilova D.N.,

Resume

Toxic epidermal necrolysis (TEN) is a rare life-threatening condition almost exclusively drug-related. The incidence in children is lower than in adults and has a better outcome. The main causative agents of TEN are sulfonamides and anticonvulsants, followed by penicillins and non-steroidal anti-inflammatory drugs. In rare cases, paracetamol is the only drug suspected. Unlike adults, allopurinol, oxicams, and nevirapine are not identified as causative agents in children, probably due to differences in drug prescription.

Key words: causes of toxic epidermal necrolysis, children, main etiological factors, sulfonamides and anticonvulsants.

First page

11

Last page

18

For citation: Khushvaktova M.F., Achilova D.N., ANALYSIS OF THE CAUSES OF TOXIC EPIDERMAL NECROLYSIS IN CHILDREN //New Day in Medicine 9 (47)2022 11-18 https://l.clck.bar/b1d98

LIST OF REFERENCES:

  1. Stevens A.M., Johnson F.C. A new eruptive fever associates with stomatitis and ophthalmia; report of two cases in children. // Am J Dis Child 1922;24:526–33.
  2. Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. // Br J Dermatol 1956;68:355–61.
  3. Roujeau J.C. The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification. // J Invest Dermatol 1994;102:28S–30S.
  4. Bastuji-Garin S., Rzany B., Stern R.S., et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. // Arch Dermatol 1993;129:92–6.
  5. Roujeau J.C., Kelly J.P., Naldi L., et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. // N Engl J Med 1995;333:1600–7.
  6. 6 Sotelo-Cruz N. Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Gac Med Mex 2012;148:265–75.
  7. Rzany B., Mockenhaupt M., Baur S., et al. Epidemiology of erythema exsudativ ummultiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990–1992): structure and results of a population-based registry. // J Clin Epidemiol 1996;49:769–73.
  8. Goyal S., Gupta P., Ryan C.M., et al. Toxic epidermal necrolysis in children: medical, surgical, and ophthalmologic considerations. // J Burn Care Res 2009;30:437–49.
  9. Lam N.S., Yang Y.H., Wang L.C., et al. Clinical characteristics of childhood erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Taiwanese children. // J Microbiol Immunol Infect 2004;37:366–70.
  10. García-Fernández D., García-Patos Briones V., Castells Rodellas A. Síndrome de Stevens/Johnson/necrólisis epidérmica tóxica. Piel 2001;16:444–57.
  11. Ho J.C., Ng P.L., Tan S.H., et al. Childhood linear IgA bullous disease triggered by amoxicillin-clavulanic acid. // Pediatr Dermatol 2007;24:E40–3.
  12. Criado P.R., Avancini J., Santi C.G., et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a complex interaction of drugs, viruses and the immune system. // Isr Med Assoc J 2012;14:577–82.
  13. Lin T.K., Hsu M.M., Lee J.Y. Clinical resemblance of widespread bullous fixed drug eruption to Stevens-Johnson syndrome ortoxic epidermal necrolysis: report of two cases. // J Formos Med Assoc 2002;101:572–6.
  14. Macias E.S., Pereira F.A., Rietkerk W., et al. Superantigens in dermatology. // J Am Acad Dermatol 2011;64:455–72.
  15. Assier H., Bastujigarin S., Revuz J., et al. Erythema multiforme with mucous-membrane involvement and Stevens-Johnson Syndrome are clinically different disorders with distinct causes. // Arch Dermatol 1995;131:539–43.
  16. Auquier-Dunant A., Mockenhaupt M., Naldi L., et al. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. // Arch Dermatol 2002;138:1019–24.
  17. Naisbitt D.J., Pirmohamed M., Park B.K. Immunopharmacology of hypersensitivity reactions to drugs. // Curr Allergy Asthma Rep 2003;3:22–9.
  18. Pavlos R., Mallal S., Phillips E. HLA and pharmacogenetics of drug hypersensitivity. // Pharmacogenomics 2012;13:1285–306.
  19. Koh M.J., Tay Y.K. An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children. // Curr Opin Pediatr 2009;21:505–10.
  20. Chung W.H., Hung S.I. Genetic markers and danger signals in Stevens-Johnson syndrome and toxic epidermal necrolysis. // Allergol Int 2010;59:325–32.
  21. Kaniwa N., Saito Y., Aihara M., et al. HLA-B locus in Japanese patients with antiepileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 2008;9:1617–22.
  22. Mockenhaupt M. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. // Expert Rev Clin Immunol 2011;7:803–13.

file

download